NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced the introduction in the U.S. of over-the-counter (OTC) Nexium® 24HR, making The Purple Pill® available for the treatment of frequent heartburn (two or more days a week) in adults (18 years and older). Heartburn affects more than 60 million men and women in the United States at least once a month with 15 million Americans suffering from it daily.1
Help employers find you! Check out all the jobs and post your resume.
